Clinical Trial

Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease

Name: Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease — clinical trial record (NCT07020026)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The study aims to evaluate the burden of tau pathology in people with Sporadic and LRRK2 PD via in vivo imaging using the tau tracer, \[18F\]PI-2620, and a high resolution PET camera, NeuroEXPLORER.

Trial Details

NCT Number	NCT07020026
Lead Sponsor	Michael J. Fox Foundation for Parkinson's Research Collaborators: Institute for Neurodegenerative Disorders
Conditions	Parkinson's Disease
Enrollment	60 participants
Start Date	2025-05-12
Primary Completion	2027-04 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-08-10